{"Q": 1, "answer": "no", "rationale": "The segment describes a vaccine deal and does not contain an intensifier modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15396", "batch_size": 200, "batch_pos": 22, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, critical alert phrase, or superlative/intensifier + harm noun.", "method": "llm_batch", "batch_id": "batch_2_19492", "batch_size": 200, "batch_pos": 188, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The segment discusses vaccine doses, not disease impact.", "method": "llm_batch", "batch_id": "batch_3_7536", "batch_size": 200, "batch_pos": 146, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment describes vaccine deal details, but does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14136", "batch_size": 200, "batch_pos": 144, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports a fact/statistic (deal secures doses) but contains no explicit calming or reassuring language.", "method": "llm_batch", "batch_id": "batch_5_19516", "batch_size": 200, "batch_pos": 141, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_20784", "batch_size": 200, "batch_pos": 103, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_21252", "batch_size": 200, "batch_pos": 100, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes a preparedness measure/resource: 'deal secures up to 665,000 doses', 'includes an option for a further 40 million vaccines'.", "method": "llm_batch", "batch_id": "batch_8_19776", "batch_size": 200, "batch_pos": 146, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
